Today: 7 February 2026
Subscribe

Dell’s AI Server Boom Doubles Growth Forecasts – Is a Data Center Glut Looming?

Dell Technologies Doubles Down on AI Factory at SC25 as Wall Street Turns Cautious — Key Developments on November 17, 2025

Published: November 17, 2025 Dell Technologies is at the center of two very different storylines today:on the ground in St. Louis, the company is unveiling one of its biggest-ever upgrades to its AI infrastructure portfolio at the SC25 supercomputing conference — while on Wall Street, its stock is sliding after a high‑profile downgrade, even as JPMorgan raises its price target. Here’s a full rundown of everything that happened around Dell Technologies on November 17, 2025, and what it means for enterprises and investors. Massive AI Factory Upgrade Unveiled at SC25 At SC25 in St. Louis, Dell Technologies announced more than
17 November 2025
Google Stock Today: Alphabet (GOOGL, GOOG) Soars on AI Boom – 2025 Update & Forecast

Google Stock Today (November 17, 2025): Alphabet Soars as Berkshire Reveals $4.9 Billion Stake

Published: November 17, 2025 – All figures intraday and subject to change. Alphabet, the parent company of Google, is back in the spotlight today as Google stock (GOOGL, GOOG) jumps to fresh 52‑week highs after Berkshire Hathaway disclosed a multibillion‑dollar stake in the tech giant. The move marks one of Warren Buffett’s last big portfolio decisions as Berkshire CEO and has turned Google stock into the story of the day on Wall Street. Reuters+1 Google stock today: price action at a glance As of early afternoon on Monday, November 17, 2025, Alphabet’s Class A shares (ticker GOOGL) were: Investing.com+1 Class
17 November 2025
·
Tax Season Shocker: Fewer Refunds but Bigger Payouts as New Tax Changes Loom

No Tax on Tips, Overtime and Seniors? States Push Back on Trump’s New Tax Breaks

When Congress passed President Donald Trump’s One Big Beautiful Bill Act (OBBBA) this summer, the headlines almost wrote themselves: “No tax on tips,” “no tax on overtime,” “$6,000 bonus deduction for seniors.” For millions of workers and retirees, it sounded like simple, sweeping tax relief starting with their 2025 returns. But as of Monday, November 17, 2025, a wave of new state‑level actions shows the reality is far messier. Washington, D.C. has already moved to block the new breaks in its local tax code, and a fresh report syndicated across Gannett outlets today confirms Illinois will also keep taxing tips
17 November 2025
US Stock Market Today, November 17, 2025: Wall Street Wobbles as Nvidia Earnings and Jobs Data Loom

US Stock Market Today, November 17, 2025: Wall Street Wobbles as Nvidia Earnings and Jobs Data Loom

New York, November 17, 2025 – The US stock market started the new week on an uncertain footing as investors braced for a packed few days of economic data and blockbuster earnings led by Nvidia, while a rare tech bet from Warren Buffett sent Alphabet shares to record highs. By late morning in New York, the Dow Jones Industrial Average was down about 0.2% near 47,100, the S&P 500 slipped around 0.1% to about 6,726, and the Nasdaq Composite hovered close to flat near 22,890, reflecting a choppy, directionless session. Reuters That muted tone comes after a volatile prior week
17 November 2025
···
Emirates Bets Big on Boeing: $38 Billion Order for 65 Boeing 777X Jets Anchors Dubai Airshow 2025

Emirates Bets Big on Boeing: $38 Billion Order for 65 Boeing 777X Jets Anchors Dubai Airshow 2025

Dubai, United Arab Emirates — November 17, 2025: Emirates has stunned the opening day of Dubai Airshow 2025 with a new order for 65 Boeing 777‑9 aircraft, a deal valued at $38 billion at list prices and built around Boeing’s delayed but strategically crucial 777X program. The purchase lifts Emirates’ total 777X commitment to 270 aircraft and takes its overall Boeing widebody orderbook to 315 jets, including 777 freighters and 787 Dreamliners. Emirates+2MediaRoom+2 The blockbuster deal is the latest twist in the story of Boeing’s next‑generation long‑haul flagship: a jet that has accumulated huge costs and multiple delays, yet continues
17 November 2025
Deutsche Bank Stock Plunges Again as Global Credit Jitters Flare – What Experts Predict Next

Deutsche Bank Investor Day 2025: New 13% RoTE Target, €37bn Revenue Goal and 250 Wealth Manager Hires

FRANKFURT/LONDON — November 17, 2025.Deutsche Bank has kicked off a new phase of its turnaround, telling investors it aims to deliver a return on tangible equity (RoTE) of more than 13% by 2028, grow revenues to about €37bn and lift shareholder payouts to 60% of net profit — while hiring up to 250 additional wealth managers to accelerate growth. Deutsche Bank+2Reuters+2 The strategy update, unveiled at the bank’s Investor Deep Dive 2025 in London, marks the most ambitious set of financial targets since Christian Sewing took over as chief executive in 2018 and vowed to stabilise a lender hit by
17 November 2025
Billion-Dollar Brawl: Novo Nordisk and Pfizer Clash in High-Stakes Obesity Drug Takeover

Novo Nordisk Slashes Wegovy and Ozempic Cash Prices to $349, Launches $199 Intro Deals as GLP‑1 Price War Escalates

Published November 17, 2025 Novo Nordisk moved aggressively today to cut out‑of‑pocket costs for its blockbuster GLP‑1 drugs Wegovy and Ozempic, unveiling new self‑pay prices and limited‑time offers that it says will reach tens of thousands of U.S. pharmacies and telehealth partners. The changes come just days after the Trump administration struck landmark pricing agreements with Novo Nordisk and Eli Lilly that will extend Medicare and Medicaid coverage to obesity drugs for the first time and launch a government-run discount pharmacy site, TrumpRx, in early 2026. The White House+2Reuters+2 At the same time, telehealth and discount platforms including GoodRx and
17 November 2025
·
Salesforce (CRM) Stock Today: Analyst Target Cuts, AI Commerce Push and What It Means for Investors — November 17, 2025

Salesforce (CRM) Stock Today: Analyst Target Cuts, AI Commerce Push and What It Means for Investors — November 17, 2025

Salesforce (NYSE: CRM) shares spent Monday under pressure, trading around the high‑$230s to low‑$240s and finishing the session near $239 per share, roughly 1.5–1.8% lower on the day, according to intraday and historical data.Investing.com The AI‑driven CRM leader is still sitting well below its 52‑week high in the mid‑$360s, despite steadily growing revenue and earnings. At the same time, Wall Street remains broadly bullish. Bank of America and Mizuho both trimmed their price targets today but kept positive ratings, while the consensus one‑year target across major brokerages still sits in the low‑$320s — implying roughly 35–38% upside from current levels.MarketBeat+2GuruFocus+2
17 November 2025
·
Kaixin Holdings (KXIN) Stock Explodes Over 100% on Heavy Volume as Traders Revisit High‑Risk AI and Crypto Bet – 17 November 2025

Kaixin Holdings (KXIN) Stock Explodes Over 100% on Heavy Volume as Traders Revisit High‑Risk AI and Crypto Bet – 17 November 2025

Kaixin Holdings (NASDAQ: KXIN) is back in the spotlight on Monday, with its stock more than doubling in volatile trade and landing among the most active names on the Nasdaq, even as the broader U.S. market trades lower. Benzinga+2Yahoo Finance+2 By late morning U.S. time on 17 November 2025, KXIN was changing hands around $0.65, up well over 100% from Friday’s close near $0.31. Different real‑time feeds show an intraday range of roughly $0.38–$0.75 and more than 180–200 million shares traded — enormous turnover for a stock whose average daily volume has recently been under 1 million shares. Investing.com+1 KXIN
17 November 2025
·
LifeMD (LFMD) Slashes Wegovy and Ozempic Cash-Pay Price to $199 as Q3 2025 Earnings and GLP‑1 Price War Heat Up

LifeMD (LFMD) Slashes Wegovy and Ozempic Cash-Pay Price to $199 as Q3 2025 Earnings and GLP‑1 Price War Heat Up

LifeMD (NASDAQ: LFMD) announced the lowest nationwide cash-pay pricing for Wegovy and Ozempic at $199 per month for new patients, just hours before its rescheduled Q3 2025 earnings release. Here’s what it means for patients, investors, and the GLP‑1 weight-loss market LifeMD Announces $199 Cash-Pay Pricing for Wegovy and Ozempic This morning, LifeMD, Inc. (NASDAQ: LFMD) unveiled what it calls the lowest cash‑pay pricing available nationwide for the GLP‑1 weight‑loss drugs Wegovy and Ozempic, in continued collaboration with Novo Nordisk. MarketScreener+3GlobeNewswire+3Quiver Quantitative+3 Under the new offer: The move builds on LifeMD’s shift away from compounded GLP‑1s toward direct partnerships with
17 November 2025
Vita Coco (COCO) Soars on Tariff Relief and BofA Upgrade as Stock Hits New High – 17 November 2025

Vita Coco (COCO) Soars on Tariff Relief and BofA Upgrade as Stock Hits New High – 17 November 2025

On Monday, 17 November 2025, shares of The Vita Coco Company, Inc. (NASDAQ: COCO) surged to fresh record levels after the White House moved to exempt coconut water from new reciprocal tariffs and Bank of America (BofA) upgraded the stock to Buy with higher 2026 profit estimates.Nasdaq+2Investing.com+2 The rally caps several weeks of strong news flow for the coconut‑water leader, including robust third‑quarter results, raised full‑year guidance, and ongoing share repurchases.TradingView+2Simply Wall St+2 Key takeaways for today (17 November 2025) COCO stock price today: rally extends to record territory As of late trading on 17 November, COCO is changing hands
17 November 2025
HPE Stock Slides on Morgan Stanley Downgrade as $714 Million H3C Sale Reshapes Its China Footprint – November 17, 2025

HPE Stock Slides on Morgan Stanley Downgrade as $714 Million H3C Sale Reshapes Its China Footprint – November 17, 2025

Hewlett Packard Enterprise (NYSE: HPE) is in the spotlight today as Wall Street reacts to a fresh analyst downgrade, a major divestment in China, and ongoing bets on AI, hybrid cloud and supercomputing. HPE shares under pressure after Morgan Stanley downgrade Hewlett Packard Enterprise started the week on the defensive as Morgan Stanley downgraded the stock to “Equal-weight” from “Overweight” and cut its price target to $25 from $28. The bank flagged what it called an “unprecedented” memory pricing cycle, with DRAM and NAND prices up roughly 50% to as much as 300% over the last six months, squeezing margins
17 November 2025
Aramark (ARMK) Slides as Q4 2025 Earnings Miss, but 2026 Outlook Stays Strong

Aramark (ARMK) Slides as Q4 2025 Earnings Miss, but 2026 Outlook Stays Strong

Aramark (NYSE: ARMK) reported its fiscal fourth‑quarter and full‑year 2025 results before the U.S. market opened on Monday, November 17, 2025. The numbers showed strong full‑year growth, record new business wins and a higher dividend — but a softer‑than‑expected Q4 and “lofty” expectations sent the stock lower in today’s session. Business Wire+2Investing.com Canada+2 By late afternoon, Aramark shares were trading around $35.98, down roughly 5–6% from Friday’s close, on heavy volume. The drop follows a pre‑market slide that earlier reached nearly 8% after investors digested the earnings miss and guidance. Investing.com Canada+1 At the same time, management laid out a
17 November 2025
·
PowerBank (SUUN) Returns to Profitability: Q1 2026 Earnings, AI Deal and Stock Reaction on 17 November 2025

PowerBank (SUUN) Returns to Profitability: Q1 2026 Earnings, AI Deal and Stock Reaction on 17 November 2025

Clean‑energy developer and IPP PowerBank Corporation (NASDAQ: SUUN, Cboe CA: SUNN) swings back to profit as it leans into solar, storage and AI‑driven project planning. PowerBank Corporation, the Canadian‑based solar and battery storage developer formerly known as SolarBank, reported a profitable first quarter of fiscal 2026 today and unveiled a fresh milestone in its AI partnership with Intellistake Technologies, sending the thinly traded renewable‑energy stock back into the spotlight. Powerbank Corporation+1 Q1 2026: PowerBank posts first quarterly profit since major write‑downs In a designated earnings release covering the three months ended 30 September 2025, PowerBank said it: Powerbank Corporation+1 Earnings
17 November 2025
···
Albemarle (ALB) Soars as Lithium Prices Spike and Argus Lifts Target to $140 – What Investors Need to Know Today (17 November 2025)

Albemarle (ALB) Soars as Lithium Prices Spike and Argus Lifts Target to $140 – What Investors Need to Know Today (17 November 2025)

Albemarle stock (NYSE: ALB) jumped around 8–9% on November 17, 2025, as lithium prices hit a one‑year high and Argus raised its price target to $140. Here’s what’s driving the move, how Wall Street is reacting, and what it could mean for investors. Albemarle stock is on fire today Albemarle stock has been in rally mode for days, but today’s move stands out even in a strong November run. German market outlet wallstreet‑online describes today’s advance as a “kräftiger Gewinn” (strong gain), pointing out that: wallstreet-online.de In other words, today is not a random pop – it’s part of a
17 November 2025
Canadian Solar (CSIQ) Stock Soars on Storage Deals, Roth Price Target Hike & Insider Sales – November 17, 2025

Canadian Solar (CSIQ) Stock Soars on Storage Deals, Roth Price Target Hike & Insider Sales – November 17, 2025

As of mid-afternoon on November 17, 2025, Canadian Solar Inc. (CSIQ) is trading around $29–30 per share, after an extremely volatile few sessions that saw the stock spike to the mid‑$30s following its Q3 2025 earnings release. MarketBeat 1. Stock performance: from laggard to November high‑flyer Canadian Solar has turned into one of November’s surprise momentum stories: Today’s action looks more like consolidation after a huge run: the real story on November 17 is in the newsflow around battery storage, analyst calls and insider activity, rather than another big price spike. 2. Q3 2025 earnings: revenue and margin beat, but
17 November 2025
··
Clearwater Analytics (CWAN) Soars on Warburg Pincus & Permira Buyout Buzz — Key Updates for November 17, 2025

Clearwater Analytics (CWAN) Soars on Warburg Pincus & Permira Buyout Buzz — Key Updates for November 17, 2025

On Monday, November 17, 2025, Clearwater Analytics Holdings, Inc. (NYSE: CWAN) once again jumped onto traders’ radar as renewed buyout speculation from private equity giants Warburg Pincus and Permira pushed the stock sharply higher in pre‑market trading and kept it among the day’s notable movers. TradingView+2Benzinga+2 Below is a full rundown of what’s driving Clearwater Analytics today, how it fits into the company’s broader AI and growth story, and what investors are watching next. CWAN Stock Today: Double‑Digit Premarket Spike, Still Volatile Mid‑Session Clearwater Analytics shares extended last week’s rally in Monday’s pre‑market session: By late morning, the move had
17 November 2025
·
E.W. Scripps (SSP) Soars as Sinclair Builds 8.2% Stake and Pushes for Takeover on November 17, 2025

E.W. Scripps (SSP) Soars as Sinclair Builds 8.2% Stake and Pushes for Takeover on November 17, 2025

On November 17, 2025, Sinclair Inc. disclosed an 8.2% stake in The E.W. Scripps Company (NASDAQ: SSP) and confirmed it is pursuing a merger, sending SSP stock more than 20% higher. Here’s what the potential Sinclair–Scripps deal means for investors, the local TV landscape and sports rights. The E.W. Scripps Company (NASDAQ: SSP) is at the center of one of the biggest media storylines of 2025 after rival broadcaster Sinclair Inc. (NASDAQ: SBGI) revealed it has quietly built an 8.2% stake in Scripps’ Class A non‑voting shares and is actively pushing for a takeover.Reuters+1 The disclosure, made in a regulatory
17 November 2025
···
Medical Properties Trust (MPW) Hikes Dividend 12% and Extends Buyback Push: What Investors Need to Know Today (17 November 2025)

Medical Properties Trust (MPW) Hikes Dividend 12% and Extends Buyback Push: What Investors Need to Know Today (17 November 2025)

Medical Properties Trust, Inc. (NYSE: MPW) is back in the headlines today after announcing a 12% increase to its regular quarterly dividend, alongside updates that underscore its ongoing recovery story and capital-return strategy. On November 17, 2025, the healthcare REIT said its board has approved a quarterly cash dividend of $0.09 per share, up from $0.08 last quarter. The dividend will be paid on January 8, 2026 to shareholders of record as of December 11, 2025. Business Wire+2MarketScreener+2 The move comes just weeks after MPW reported third-quarter results, unveiled a $150 million common stock repurchase program, and continued to reshape
17 November 2025
Repare Therapeutics (RPTX) Soars on XenoTherapeutics Takeover Deal: Cash + CVR Offer, Analyst Downgrade and What to Watch on 17 November 2025

Repare Therapeutics (RPTX) Soars on XenoTherapeutics Takeover Deal: Cash + CVR Offer, Analyst Downgrade and What to Watch on 17 November 2025

Repare Therapeutics Inc. (NASDAQ: RPTX) is back in the spotlight today after investors digested last week’s surprise acquisition agreement with XenoTherapeutics, Inc., a Massachusetts-based non‑profit biotech. The stock is trading sharply higher and unusually active as the market prices in a mostly cash takeover and a complex contingent value right (CVR) structure that could unlock additional upside over the coming decade. Repare Therapeutics+1 As of this afternoon’s session, RPTX is changing hands around the low‑$2 range, not far above the estimated US$1.82 per‑share cash consideration embedded in the deal, and up close to 30% versus pre‑announcement levels, reflecting a classic
17 November 2025
·
1 … 1,294 1,295 1,296 1,297 1,298 … 1,632

Stock Market Today

Costco stock price retakes $1,000 — what traders are watching before Monday

Costco stock price retakes $1,000 — what traders are watching before Monday

7 February 2026
Costco closed Friday up 1.2% at $1,001.16, regaining the $1,000 level as about 2.36 million shares changed hands. January net sales rose 9.3% to $21.33 billion, with comparable sales up 7.1% and online sales surging 34.4%. Wells Fargo raised its price target to $950, maintaining a neutral rating. The next earnings call is set for March 5.
Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

7 February 2026
Johnson & Johnson shares rose 0.9% to $239.99 Friday after a New Jersey appeals court disqualified Beasley Allen from state talc cases, citing improper coordination with a former J&J attorney. The ruling affects about 3,600 state lawsuits, while a related federal motion is pending. J&J also reported early 12-month pilot data for its investigational AFib device at a cardiology meeting.
Go toTop